Medtronic (NYSE:MDT) has agreed to acquire all outstanding shares of spinal surgery device maker Medicrea (OTCQX:MRNTF) at €7.00/share, representing a 22% premium over yesterday’s closing price.
The tender offer is expected to be filed with the French Markets Authority in September.
The deal should close by year-end.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.